Dr. Shi of EdgeTech Law: Despite Mayo Clinic v. Prometheus “Setback,” Opportunities in Life Sciences Remain
OneMedPlace is pleased to announce a special interview series exploring current issues facing the diagnostics sector and life sciences.
OneMedPlace is pleased to announce a special interview series exploring current issues facing the diagnostics sector and life sciences.
This is Part II of our special report on PTSD, a survey of the rising causes for concern and potential treatments to combat it.
In response to a recent press release from TONIX Pharmaceuticals, a leading company in the exploration of alternative PTSD treatment, we are issuing a 2-part special report looking at recent developments
Reed Smith LLP, a global business law firm, recently issued a JOBS Act bulletin to its network. The bulletin, co-authored by seven partners on both coasts, summarizes and analyzes the JOBS Act.
Part Three of our Special Report analyzes what may be one of the first ‘test cases’ of the new patent infringement precedent.
Part two of our Special Report highlight an important case that may significantly affect the patent infringement landscape. Shares of Myriad Genetics fell 10 percent in the wake of the Mayo ruling.
OneMedPlace is publishing a special in-depth look into the state of patent infringement in drug manufacturing.
Unlike technology, entertainment, retail and other sectors, novel medical technologies and therapeutics take years of pre-development, and require institutional manpower to further growth.
The Food and Drug Administration must act quickly to enforce a largely ignored 35-year-old mandate prohibiting non-medical use of antibiotics in farm animals.
Despite political contention over the influence of corporate America in shaping the American Dream, our nation’s leaders tend to unite in their respect of small business.
Copyright © 2024 | WordPress Theme by MH Themes